Covered recipient · General Payments record
MONARCH SHAH
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2024
$1,098.30
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,020.87 | 39 |
| Education | $77.43 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SHIELD THERAPEUTICS INC | $108.49 | 3 |
| AKEBIA THERAPEUTICS INC | $88.90 | 4 |
| Medtronic, Inc. | $84.79 | 1 |
| Veloxis Pharmaceuticals, Inc. | $71.27 | 1 |
| Ardelyx, Inc. | $68.36 | 3 |
| Amgen Inc. | $64.52 | 2 |
| Mallinckrodt Hospital Products Inc. | $61.16 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $58.68 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $54.24 | 2 |
| Retrophin, Inc. | $52.17 | 4 |
| Xeris Pharmaceuticals, Inc. | $48.21 | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $45.92 | 2 |
| GlaxoSmithKline, LLC. | $41.71 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.92 | 2 |
| Acerta Pharma LLC | $28.87 | 1 |
| Otsuka America Pharmaceutical, Inc. | $28.58 | 1 |
| Mozarc Medical US LLC | $25.51 | 1 |
| Aurinia Pharma U.S., Inc. | $24.90 | 1 |
| Fresenius USA Marketing, Inc. | $24.86 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.77 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $20.43 | 1 |
| Kyowa Kirin, Inc. | $19.68 | 1 |
| bioMerieux | $19.36 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $1,098.30 | 42 |
Payment records · PY2024 (42)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.